Technology Assessment Submissions Required Under UK's NICE Timeline
This article was originally published in The Gray Sheet
Executive SummaryManufacturers of autologous cartilage products have six months to assemble clinical and cost-effectiveness data for submission to the UK's National Institute for Clinical Excellence.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.